Rezolute (RZLT) Interest & Investment Income (2012 - 2026)
Rezolute recorded quarterly Interest & Investment Income of $1.2 million in Q1 2026, down 17.42% quarter-over-quarter from $1.4 million in Q4 2025, and up 7.17% year-over-year from $1.1 million in Q1 2025.
Rezolute's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 7.17% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.8 million (up 13.61% YoY), while the FY2025 annual figure was $5.5 million, up 12.57% from the prior year.
- Interest & Investment Income came in at $1.2 million for Q1 2026 at Rezolute, down from $1.4 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.7 million in Q3 2025 to a low of -$442000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.3 million in 2023 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 6600.0% in 2022 and fell as far as 11150.0% in 2022.
- Rezolute's Interest & Investment Income stood at $849000.0 in 2022, then surged by 53.47% to $1.3 million in 2023, then grew by 3.15% to $1.3 million in 2024, then climbed by 7.66% to $1.4 million in 2025, then decreased by 17.42% to $1.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.2 million, $1.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 849,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | -442,000.00 |
| Dec 31, 2021 | -445,000.00 |
| Sep 30, 2021 | -443,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 55,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 30,000.00 |
| Dec 31, 2019 | 54,000.00 |
| Sep 30, 2019 | 99,000.00 |
| Jun 30, 2019 | -346,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Dec 31, 2018 | 287,000.00 |
| Sep 30, 2018 | 108,000.00 |
| Jun 30, 2018 | 23.00 |
| Mar 31, 2018 | 116.00 |
| Dec 31, 2017 | 524.00 |
| Sep 30, 2017 | 337.00 |
| Mar 31, 2016 | 1.00 |
| Dec 31, 2015 | 193.00 |
| Sep 30, 2015 | 771.00 |
| Jun 30, 2015 | 908.00 |
| Mar 31, 2015 | 1,093.00 |
| Dec 31, 2014 | 1,275.00 |
| Sep 30, 2014 | 1,694.00 |
| Jun 30, 2014 | 1,680.00 |
| Mar 31, 2014 | 3,667.00 |
| Dec 31, 2013 | 3,379.00 |
| Sep 30, 2013 | 3,454.00 |
| Jun 30, 2013 | 3,341.00 |
| Mar 31, 2013 | 13,801.00 |
| Dec 31, 2012 | 71,972.00 |
| Sep 30, 2012 | 16,930.00 |
| Jun 30, 2012 | 24,436.00 |
| Mar 31, 2012 | 9,461.00 |